Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Addex Therapeutics (ADXN)

Annual Return

Over the past 3 years, ADXN has had an average annual return of -22.73%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, ADXN has had an average annual return of -49.72%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Jan 29, 2020, ADXN has had an average annual return of -45.07%, underperforming the benchmark SPY, which returned +15.73% annual.

2026202520242023202220212020
-16.17%+10.37%+15.31%-51.95%-89.97%-53.06%-7.59%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-0.75%-4.92%-13.55%+10.60%-4.58%-2.62%-16.17%
2025+10.37%+10.15%-13.65%+6.32%+2.97%+16.97%-12.65%-3.89%+19.85%-3.68%-15.92%+0.76%+10.37%
2024+70.81%-8.12%+34.45%-40.14%+12.50%-4.71%-0.71%+33.10%-9.89%-0.30%-10.71%-19.67%+15.31%
2023+69.66%+91.60%-53.82%-25.11%-8.38%-19.87%+7.52%-16.58%-17.70%-18.11%-11.98%+9.42%-51.95%
2022-8.90%-7.34%-4.34%+1.97%-27.21%-69.50%+0.63%-6.64%-25.91%+6.16%-9.39%-18.08%-89.97%
2021-19.74%-0.97%-1.42%-6.85%-4.40%+2.25%+3.03%-1.27%-7.35%-12.44%-11.16%-10.26%-53.06%
2020-6.90%-16.29%-41.59%+13.03%-2.41%+19.74%+6.62%+60.95%-17.98%-10.10%-11.24%+36.86%-7.59%

Drawdown analysis of Addex Therapeutics (ADXN)

The maximum drawdown for the ADXN was -98.93%, occurring on Dec 18, 2023. This drawdown has not yet recovered.

The current ADXN drawdown is -98.66%.

Since Jan 29, 2020 ADXN has experienced the following drawdowns:

  • 50% or more: 3 times
  • 40% or more: 3 times
  • 30% or more: 3 times
  • 20% or more: 3 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-98.93%Dec 24, 2020749Dec 18, 2023OngoingOngoingOngoing
-57.31%Jan 29, 202033Mar 23, 202096Aug 7, 2020129
-53.38%Aug 7, 202079Nov 30, 202018Dec 24, 202097